44 related articles for article (PubMed ID: 35359046)
21. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
23. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
[No Abstract] [Full Text] [Related]
25. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
[TBL] [Abstract][Full Text] [Related]
26. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and age-wise distribution of Human Papillomavirus type 16/18 infections among hospital screened women of a peri-urban area in West Bengal: Impact of socio-demographic factors.
Bhattacharya A; Sen S; Mandal P; Sharma Saha S; Sarkar S; Pathak OP; Biswas L; Roy J; Banerjee R; Roy Chowdhury R; Pal M; Mukherjee A; Sengupta S
Cancer Epidemiol; 2018 Jun; 54():31-37. PubMed ID: 29571035
[TBL] [Abstract][Full Text] [Related]
28. Distribution of human papillomavirus types in different histological subtypes of cervical adenocarcinoma.
Hadzisejdć I; Krasević M; Haller H; Grahovac B
Coll Antropol; 2007 Apr; 31 Suppl 2():97-102. PubMed ID: 17600937
[TBL] [Abstract][Full Text] [Related]
29. Distribution and incidence of atypical glandular lesions in cervical cytology focusing on the association with high-risk human papillomavirus subtypes.
Abbas M; De Jonge J; Bettendorf O
Oncol Lett; 2023 Jan; 25(1):6. PubMed ID: 36419751
[TBL] [Abstract][Full Text] [Related]
30. A Snapshot of the Landscape of Endocervical Adenocarcinoma in Kenya: What Has HPV Got to Do with It?
Wawire J; Njenga P; Moloo Z; Sung CJ; Quddus MR
Ann Clin Lab Sci; 2022 Jul; 52(4):621-627. PubMed ID: 36197776
[TBL] [Abstract][Full Text] [Related]
31. Predictors of treatment failure for adenocarcinoma
Belkić K; Andersson S; Alder S; Mints M; Megyessi D
Oncol Lett; 2022 Oct; 24(4):357. PubMed ID: 36168314
[TBL] [Abstract][Full Text] [Related]
32. Interest of cytology combined with Xpert
Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
[TBL] [Abstract][Full Text] [Related]
33. Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix.
Stuebs FA; Gass P; Dietl AK; Schulmeyer CE; Adler W; Geppert C; Hartmann A; Knöll A; Beckmann MW; Koch MC
Arch Gynecol Obstet; 2021 Sep; 304(3):751-758. PubMed ID: 33538863
[TBL] [Abstract][Full Text] [Related]
34. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence and frequencies of human papilloma virus types in adenocarcinoma in situ of the uterine cervix].
Jin J; Luo RK; Zhao J; Ning YQ; Qu X; Tao XR; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):338-343. PubMed ID: 35359046
[No Abstract] [Full Text] [Related]
36. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
37. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
